Here’s what you need to know:
1. The global hip and knee orthopedic surgical robots market, which was valued at $83 million in 2015, is expected to reach $4.5 billion by 2022.
2. This growth is driven by new robotic devices and systems along with a rising geriatric population, which is increasing demand for joint surgeries, particularly noteworthy in the United States.
3. A key barrier to growth is decreasing insurance payments, which encourages hospitals to cut costs.
4. Major market players include Stryker, Smith & Nephew and Johnson & Johnson.
More articles on orthopedics:
Orthopedic procedures see up to 43% direct cost savings in ASC setting: 3 study insights
How are TJR patients in US & Switzerland different? 5 study insights
AAOS receives continuing medical education accreditation with commendation: 3 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.